Arab European Medical Equipment Competitors and Similar CompaniesClear all

Arab European Medical Equipment's competitors and similar companies include Beijing Aeonmed, WIN-Partners, Sientra and Paragon 28.

	Arab European Medical Equipment Arab European Medical Equipment is a supplier of medical equipment, furniture, and surgical instruments.	Beijing Aeonmed Beijing Aeonmed is a medical device manufacturing company.	WIN-Partners WIN-Partners (ウイン・パートナーズ) is a company that distributes medical devices.	Sientra Sientra is a company that develops and sells medical aesthetics products.	Paragon 28 Paragon 28 is a medical device company focused on the foot and ankle orthopedic technologies.
Founding Date	Founding Date 1996	Founding Date 2001	Founding Date 2013	Founding Date 2003	Founding Date 2010
Type	Type Private	Type Private	Type Public	Type Public	Type Public
Tags	Tags Healthcare distribution medical devices	Tags Healthcare distribution medical devices	Tags Healthcare distribution medical devices	Tags Healthcare distribution medical devices	Tags Healthcare medical devices medtech surgical solutions
Locations	Locations Dubai, AE HQ دبي, AE	Locations CN HQ	Locations Chuo City, JP HQ	Locations Irvine, US HQ	Locations Englewood, US HQ Dublin, IE Ada, US
Employees	Employees 6	Employees 2841% increase	Employees 629	Employees 3045% decrease	Employees 57424% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 232 m	Valuation ($) 2.1 m	Valuation ($) 433.6 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ¥90.4b (FY, 2026)	Revenue (est.) $90.5m (FY, 2022)	Revenue (est.) $256.2m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ¥79.4b (FY, 2026)	Cost of goods $49m (FY, 2022)	Cost of goods $64.7m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ¥11b (FY, 2026)	Gross profit $41.6m (FY, 2022)	Gross profit $191.5m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income ¥2.1b (FY, 2026)	Net income ($73.3m) (FY, 2022)	Net income ($54.6m) (FY, 2024)